Vemurafenib: Development of resistance during treatment for malignant melanoma: case report

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1373, 2011-01, pp. : 30-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natalizumab: Malignant melanoma: case report

Reactions Weekly, Vol. 1, Iss. 1341, 2011-01 ,pp. : 24-25

Adis International

Access to resources Recommend Favorite

Alemtuzumab: Malignant melanoma: case report

Reactions Weekly, Vol. 1, Iss. 1250, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Tocilizumab: First report of malignant melanoma: case report

Reactions Weekly, Vol. 1, Iss. 1418, 2012-01 ,pp. : 43-44

Adis International

Access to resources Recommend Favorite

Caspofungin: Development of resistance during treatment for invasive candidiasis, resulting in fatal multiple organ failure: case report

Reactions Weekly, Vol. 1, Iss. 1229, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Infliximab: Malignant melanoma in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1261, 2009-01 ,pp. : 16-17

Adis International

Access to resources Recommend Favorite